Loading clinical trials...
Loading clinical trials...
A Pilot Study Evaluating the Efficacy of Apremilast in the Treatment of Subjects With Severe Recurrent Aphthous Stomatitis (RAS)
Conditions
Interventions
Apremilast 30mg
Locations
1
United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Start Date
October 12, 2018
Primary Completion Date
July 14, 2021
Completion Date
July 14, 2021
Last Updated
July 14, 2022
NCT07229469
NCT04265001
NCT02920658
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions